FDA grants Breakthrough Therapy status to NVS's ianalumab for Sjogren's disease with plans for global filings starting in 2026.
The global skin-lightening market is worth over $10 billion and growing, but the unregulated products driving it contain ...
Epinephrine is a commonly used agent for a variety of indications and clinical scenarios within the emergency department. It is commonly administered during cardiopulmonary arrest and serves as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback